Belfast-based AMPLY raises £900k to tackle drug-resistant pathogens with AI

Belfast-based startup AMPLY has raised £900,000 in a joint equity and grant funding round to develop new products that tackle global disease threats from multi-drug resistant pathogens using its AI drug discovery platform. Founded as a spinout from the Queen’s University Belfast in 2021, AMPLY’s AI drug discovery platform was developed to ensure new generations… The post Belfast-based AMPLY raises £900k to tackle drug-resistant pathogens with AI appeared first on AMPLY Discovery .